Medtronic, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 121   

Articles published

MDT 74.62 -0.01 (-0.01%)
price chart
Medtronic (MDT) Launches 2 CRT Quadripolar Leads in US
Medical technology giant Medtronic Inc. (MDT - Analyst Report) recently launched two Attain Performa left ventricular (LV) quadripolar leads - the S-shape and Straight leads - in the U.S.
Medtronic (MDT) Launches 2 CRT Quadripolar Leads in US - Analyst Blog  Nasdaq
Related articles »  
Medtronic's acquisition of Covidien step closer to completion
�This regulatory clearance represents an important milestone in bringing our companies together,� Omar Ishrak, the Medtronic chief executive, said in a statement. Currently, only C.R. Bard Inc. of New Jersey has approval in the United States to sell ...
Dividend Aristocrats In Focus Part 44: Medtronic (MDT)  Seeking Alpha
Medtronic Acquisition of Covidien Receives US FTC Clearance  MarketWatch
Related articles »  
Form 8.3 - Medtronic Inc
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future ...
Medtronic's $17 Billion Bond Sale Is Year's Largest
In the race to tap bond investors for cash, Medtronic Inc. has outdone Apple Inc. and Alibaba Group Holding Ltd. The Minneapolis medical-device maker completed the largest corporate-debt sale of the year Monday, raising $17 billion in a deal that ...
Medtronic selling at least $10 billion of bonds for Covidien acquisition  MarketWatch
Medtronic-Covidien Deal Wins European Commission Go-Ahead
Related articles »  
The Zacks Analyst Blog Highlights: CVS Health, Medtronic, Medical and Rite Aid
Another noted player in the medical sector - Medtronic Inc. (NYSE: MDT-Free Report) - also raised its quarterly dividend by 9% to 30.5 cents in Jun 2014.
CVS Health Up on Dividend Hike, Fresh Buyback, Outlook
Related articles »  
Stock Update: Medtronic Inc. (NYSE:MDT)
[Zacks] Medtronic, Inc. (NYSE:MDT) - Several important product approvals as well as label expansions were gained this year.
Covidien-Medtronic Deal Moves Closer to the Finish Line
Medtronic Inc.'s $43 billion acquisition of Ireland's Covidien COV -0.30% PLC moved one step closer to the finish line Thursday.
Form 8-K MEDTRONIC INC For: Dec 04 (subscription)
Medtronic and Covidien's Blockbuster Medical Products Merger Clears FTC ...  The National Law Review
Related articles »  
Medtronics $17B Corporate Bond Sale Breaks 2014 Records
Beating all the major corporate bond issuances this year, Medtronic Inc. (MDT - Analyst Report) recently announced a colossal $17 billion corporate-bond sale to fund the mega $42 billion purchase of its Irish rival Covidien plc (COV - Analyst Report).
5 Charts: Medtronic, Bonds and M&A  Wall Street Journal (blog)
Corporate Bond Sales Surpass Record $1.5 Trillion In 2014  Barron's (blog)
Related articles »  
Medtronic acquisition could be done by late January
Both commissions approved the deal contingent upon Medtronic divesting Covidien's drug-coated balloon catheter product.
Medtronic-Covidien Deal Nears Finish Line, Approvals Flow In
Medtronic Inc.'s (MDT - Analyst Report) proposed $42.9 billion acquisition of Covidien plc (COV - Analyst Report) is in its last leg as regulatory go-aheads continue to usher in.
Medtronic-Covidien Merger Receives Regulatory Approval From China, South ...  Med Device Online (press release)
Related articles »